Neurofilament accumulation disrupts autophagy in giant axonal neuropathy

被引:0
|
作者
Paumier, Jean-Michel [1 ]
Zewe, James [1 ]
Panja, Chiranjit [1 ]
Pergande, Melissa R. [1 ,4 ]
Venkatesan, Meghana [1 ]
Israeli, Eitan [1 ,5 ]
Prasad, Shikha [1 ]
Snider, Natasha [2 ]
Savas, Jeffrey N. [1 ]
Opal, Puneet [1 ,3 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol, Chicago, IL USA
[2] Univ North Carolina Chapel Hill, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC USA
[3] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL USA
[4] Boston Univ, Dept Chem, Boston, MA USA
[5] Hebrew Univ Jerusalem, Fac Med, Hadassah Med Sch, Barry Skolnick Biosafety Level Unit 3, Jerusalem, Israel
关键词
PROTEIN; GIGAXONIN; MATURATION; CLEARANCE; LYSOSOMES; FAMILY;
D O I
10.1172/jci.insight.177999
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Neurofilament accumulation is associated with many neurodegenerative diseases, but it is the primary pathology in giant axonal neuropathy (GAN). This childhood-onset autosomal recessive disease is caused by loss-of-function mutations in gigaxonin, the E3 adaptor protein that enables neurofilament degradation. Using a combination of genetic and RNA interference approaches, we found that dorsal root ganglia from mice lacking gigaxonin have impaired autophagy and lysosomal degradation through 2 mechanisms. First, neurofilament accumulations interfere with the distribution of autophagic organelles, impairing their maturation and fusion with lysosomes. Second, the accumulations attract the chaperone 14-3-3, which is responsible for the proper localization of the key autophagy regulator transcription factor EB (TFEB). We propose that this dual disruption of autophagy contributes to the pathogenesis of other neurodegenerative diseases involving neurofilament accumulations.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] NEUROPHYSIOLOGY OF GIANT AXONAL NEUROPATHY
    Lehky, Tanya
    Saade, Dimah
    Inati, Sara
    Bonnemann, Carsten
    Bharucha-Goebel, Diana
    MUSCLE & NERVE, 2019, 60 : S121 - S121
  • [22] GIANT AXONAL NEUROPATHY - A REVIEW
    OUVRIER, RA
    BRAIN & DEVELOPMENT, 1989, 11 (04): : 207 - 214
  • [23] CONGENITAL GIANT AXONAL NEUROPATHY
    KINNEY, RB
    GOTTFRIED, MR
    HODSON, AK
    AUTILIOGAMBETTI, L
    GRAHAM, DG
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1985, 109 (07) : 639 - 641
  • [24] Giant axonal neuropathy and anaesthesia
    Diagos, P
    Bos, JAG
    Verrips, A
    Booij, LHDJ
    ANAESTHESIA, 2003, 58 (07) : 723 - 724
  • [25] AXONAL CYTOSKELETAL ABNORMALITIES IN GIANT AXONAL NEUROPATHY (GAN)
    DONAGHY, M
    BRETT, EM
    KING, RHM
    THOMAS, PK
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1988, 51 (05): : 736 - 736
  • [26] INHERITED CANINE GIANT AXONAL NEUROPATHY
    DUNCAN, ID
    GRIFFITHS, IR
    CARMICHAEL, S
    HENDERSON, S
    MUSCLE & NERVE, 1981, 4 (03) : 223 - 227
  • [27] INHERITED CANINE GIANT AXONAL NEUROPATHY
    HARTIGAN, PJ
    IRISH VETERINARY JOURNAL, 1984, 38 (7-8) : 138 - 138
  • [28] ANESTHESIA FOR A PATIENT WITH GIANT AXONAL NEUROPATHY
    MITCHELL, A
    MOSKOVITS, PE
    ANAESTHESIA, 1991, 46 (06) : 469 - 470
  • [29] Giant Axonal Neuropathy and Precocious Puberty
    Miller, Jennifer Lynn
    Roth, Lisa Anne
    Zimmerman, Donald
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [30] Anaesthesia recommendations for Giant axonal neuropathy
    Sharkey, Emma
    Griffiths, Sian E. M.
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2020, 61 : S273 - S280